<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>NewAmsterdam Pharma Company N.V. (NAMS) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/nams/filings</link>
    <description>Latest company filings for NewAmsterdam Pharma Company N.V. (NAMS) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 07:49:10 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/nams/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000491/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000491</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526224656/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-224656</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526210283/nams-20260507.htm</link>
      <guid isPermaLink="false">0001193125-26-210283</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526210272/nams-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-210272</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526207564/nams_2025_10-k_ars.pdf</link>
      <guid isPermaLink="false">0001193125-26-207564</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Annual report to shareholders (ARS) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526207562/nams-20260506.htm</link>
      <guid isPermaLink="false">0001193125-26-207562</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Proxy statement (DEF 14A) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[NAMS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000031506626001273/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-001273</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526177406/nams-20260420.htm</link>
      <guid isPermaLink="false">0001193125-26-177406</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Major company event (8-K) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526162757/nams-20260420.htm</link>
      <guid isPermaLink="false">0001193125-26-162757</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a PRE 14A (PRE 14A) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526104239/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-104239</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000272/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000272</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526100798/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-100798</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526099073/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-099073</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000241/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000241</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-03-06.]]></description>
      <pubDate>Fri, 06 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000230/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000230</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000187/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000187</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526085947/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-085947</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526084266/nams-20260302.htm</link>
      <guid isPermaLink="false">0001193125-26-084266</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Major company event (8-K) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526078718/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-078718</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000152/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000152</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-02-24.]]></description>
      <pubDate>Tue, 24 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526067260/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-067260</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-02-24.]]></description>
      <pubDate>Tue, 24 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000208592926000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002085929-26-000002</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-02-20.]]></description>
      <pubDate>Fri, 20 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526056037/nams-20260218.htm</link>
      <guid isPermaLink="false">0001193125-26-056037</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Employee stock plan (S-8) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526056029/nams-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-056029</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Annual report (10-K) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526056020/nams-20260218.htm</link>
      <guid isPermaLink="false">0001193125-26-056020</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Major company event (8-K) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000090514826000880/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-26-000880</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NAMS: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000031506626000486/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-000486</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526029526/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-029526</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-29.]]></description>
      <pubDate>Thu, 29 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526025012/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-025012</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526019686/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-019686</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-22.]]></description>
      <pubDate>Thu, 22 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000040/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000040</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-20.]]></description>
      <pubDate>Tue, 20 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009274/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009274</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009273/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009273</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009272/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009272</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009271/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009271</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009270/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009270</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009269/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009269</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009268/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-009268</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526008300/nams-20260109.htm</link>
      <guid isPermaLink="false">0001193125-26-008300</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Major company event (8-K) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000197449426000023/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974494-26-000023</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526006662/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006662</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526006659/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006659</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526006658/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006658</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858226000015/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-26-000015</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000197449426000017/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974494-26-000017</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000197449426000015/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974494-26-000015</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000197449426000013/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974494-26-000013</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312525335513/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-335513</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider trade (4) on 2025-12-29.]]></description>
      <pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NAMS: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000196858225001282/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001968582-25-001282</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a Insider sale notice (144) on 2025-12-23.]]></description>
      <pubDate>Tue, 23 Dec 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NAMS: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312525308141/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-25-308141</guid>
      <description><![CDATA[NewAmsterdam Pharma Company N.V. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2025-12-04.]]></description>
      <pubDate>Thu, 04 Dec 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
  </channel>
</rss>